Group One Trading
CABA icon

Group One Trading’s Cabaletta Bio CABA Stock Holding History

Group One Trading’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42K Sell
900
-37,000
-98% -$103K ﹤0.01% 6992
2025
Q4 		$83K Buy
37,900
+14,600
+63% +$36.2K ﹤0.01% 5152
2025
Q3 		$54.5K Buy
23,300
+16,200
+228% +$27.8K ﹤0.01% 5888
2025
Q2 		$10.8K Sell
7,100
-20,700
-74% -$32.3K ﹤0.01% 6669
2025
Q1 		$38.5K Sell
27,800
-24,800
-47% -$52.8K ﹤0.01% 5357
2024
Q4 		$119K Buy
52,600
+49,200
+1,447% +$173K ﹤0.01% 4367
2024
Q3 		$16K Sell
3,400
-28,200
-89% -$163K ﹤0.01% 5355
2024
Q2 		$236K Sell
31,600
-57,000
-64% -$699K ﹤0.01% 3256
2024
Q1 		$1.51M Buy
88,600
+86,600
+4,330% +$1.86M 0.01% 1723
2023
Q4 		$45.4K Buy
2,000
+1,900
+1,900% +$31.9K ﹤0.01% 5141
2023
Q3 		$1.52K Hold
100
– – ﹤0.01% 7126
2023
Q2 		$1.29K Buy
+100
New +$1.08K ﹤0.01% 7211
2022
Q1 		– Sell
-1,700
Closed -$6K – 8063
2021
Q4 		$6K Buy
+1,700
New +$18.1K ﹤0.01% 7568

Other funds holding CABA

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Group One Trading's CABA Position: Q3 2024 in Review

Group One Trading sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 20,669 shares — an estimated $120K sold.

Group One Trading first reported a position in CABA in Q3 2021 and held it in 5 quarters. The position peaked at $155K in Q2 2024. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Group One Trading reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Group One Trading sold 20,669 Cabaletta Bio shares in Q3 2024, an estimated $120K.
  • Group One Trading first reported a position in Cabaletta Bio in Q3 2021 and held it in 5 quarters.
  • Group One Trading's Cabaletta Bio position peaked at $155K in Q2 2024.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Group One Trading's 13F filing for Q3 2024, filed 14 Nov 2024.